Immuneering annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Immuneering Depreciation & Amortization Growth & History (IMRX)
Immuneering's depreciation and amortization was $324,517 for fiscal 2025.
View full Immuneering company overviewImmuneering annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $324,517 | −$31,290 | −8.79% |
| 2024 | 2024-12-31 | $355,807 | $32,991 | +10.22% |
| 2023 | 2023-12-31 | $322,816 | $45,564 | +16.43% |
| 2022 | 2022-12-31 | $277,252 | $231,785 | +509.79% |
| 2021 | 2021-12-31 | $45,467 | $21,139 | +86.89% |
| 2020 | 2020-12-31 | $24,328 | — | — |
Immuneering quarterly depreciation and amortization
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $84,454 | −$73 | −0.09% |
| Q1 2026 | 2026-03-31 | $81,402 | −$3,859 | −4.53% |
| Q4 2025 | 2025-12-31 | $83,206 | — | — |
| Q3 2025 | 2025-09-30 | $78,841 | −$10,108 | −11.36% |
| Q2 2025 | 2025-06-30 | $84,527 | −$6,006 | −6.63% |
| Q1 2025 | 2025-03-31 | $85,261 | −$4,948 | −5.49% |
| Q3 2024 | 2024-09-30 | $88,949 | $10,655 | +13.61% |
| Q2 2024 | 2024-06-30 | $90,533 | $12,291 | +15.71% |
| Q1 2024 | 2024-03-31 | $90,209 | $13,682 | +17.88% |
| Q3 2023 | 2023-09-30 | $78,294 | $10,219 | +15.01% |
| Q2 2023 | 2023-06-30 | $78,242 | $23,682 | +43.41% |
| Q1 2023 | 2023-03-31 | $76,527 | $20,720 | +37.13% |
| Q3 2022 | 2022-09-30 | $68,075 | $56,097 | +468.33% |
| Q2 2022 | 2022-06-30 | $54,560 | $44,753 | +456.34% |
| Q1 2022 | 2022-03-31 | $55,807 | $46,940 | +529.38% |
| Q3 2021 | 2021-09-30 | $11,978 | $6,322 | +111.78% |
| Q2 2021 | 2021-06-30 | $9,807 | $3,891 | +65.77% |
| Q1 2021 | 2021-03-31 | $8,867 | — | — |
| Q3 2020 | 2020-09-30 | $5,656 | — | — |
| Q2 2020 | 2020-06-30 | $5,916 | — | — |
Immuneering depreciation and amortization trends
Over the last five fiscal years, Immuneering's depreciation and amortization increased from $24,328 to $324,517, a change of $300,189. The latest reported quarter, Q2 2026, shows $84,454.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immuneering source filings ↗